-
Israel Englander's Millennium Cuts Stakes In Nvidia, Microsoft, And Meta While Boosting Amazon Bet In Q1 Amid Strategic Talks With BlackRock, Goldman Sachs
Friday, May 23, 2025 - 3:15am | 513Israel Englander‘s Millennium Management trimmed its positions in major technology stocks while increasing its Amazon.com Inc. (NASDAQ:AMZN) exposure during the first quarter of 2025, according to its 13F filing with the U.S. Securities and Exchange Commission on May 15. What Happened: The...
-
Millennium Management's Bitcoin And Ethereum ETFs Purchased In Q4 Suffer $22.7 Million Loss Amid Crypto Slump
Thursday, April 17, 2025 - 5:36am | 450Israel Englander‘s Millennium Management purchased Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) exchange-traded funds in the fourth quarter, according to a February 14 13F-HR filing with the U.S. Securities and Exchange Commission, but these investments have significantly declined in...
-
Blackrock In Early Talks To Take Equity Stake In Hedge Fund Giant Millennium: Report
Friday, November 8, 2024 - 1:52am | 472BlackRock Inc. (NYSE:BLK), the world’s largest asset manager, is reportedly in preliminary discussions to acquire an equity stake in Millennium Management, one of the leading hedge fund managers. What Happened: BlackRock is considering a strategic partnership with Millennium Management, the...
-
25 Interesting Facts About Forbes' 25 Highest-Earning Hedge Fund Managers
Tuesday, March 28, 2017 - 4:17pm | 1379Forbes was out with its compilation of the 25 highest-earnings hedge fund managers and traders. In the same vein, Benzinga is presenting readers with interesting facts about the 25 successful hedge fund managers/traders. 1. James Simons Of Renaissance Technologies Corp. The flagship fund of...
-
CEOs Vs. Hedge Fund Managers: Who Gets Paid Better?
Thursday, May 26, 2016 - 10:49am | 715Do you want to become a billionaire? What about running a company? Ever wondered if you’d get richer making it to CEO or as a money manager? Well, Benzinga’s got some pointers for you. The Associated Press and Equilar, an executive data firm, recently published a list of the 10 highest-...
-
The Baker Brothers Are Bullish On Seattle Genetics And DBV Technologies
Wednesday, September 16, 2015 - 3:51pm | 426On late Tuesday, hedge fund Baker Bros. Advisors, managed by Julian and Felix Baker, filed two Schedule 13Ds with the SEC, disclosing moves in DBV Technologies SA - ADR (NASDAQ: DBVT) and Seattle Genetics, Inc. (NASDAQ: SGEN). The firm disclosed an increase in its stake in Seattle Genetics and a...
-
Black Monday Didn't Stop Mr. Shaw & Mr. Cohen
Tuesday, August 25, 2015 - 7:22am | 342On a day where markets fell considerably, two major hedge fund managers disclosed noteworthy stock moves with the SEC. Steven Cohen Steven Cohen’s Point72 Asset Management disclosed a new position in small-cap clinical-stage biopharmaceutical company Inotek Pharmaceuticals Corp (NASDAQ...
-
Christian Leone, Kevin Kotler Up Bets On Two Small-Caps
Wednesday, August 12, 2015 - 7:26pm | 424Keeping track of hedge fund moves can provide valuable, research-backed investment ideas. So, let’s take a look at some of Wednesday’s top hedge fund moves. Christian Leone New York-based fund Luxor Capital Group, managed by Christian Leone, almost tripled its exposure to RCS...
-
3 Small-Caps Chuck Royce Is Getting Bullish On
Wednesday, August 5, 2015 - 5:12pm | 280In three separate SEC filings, Chuck Royce’s Royce & Associates disclosed three bullish moves. The firm boosted its exposure to Winnebago Industries, Inc. (NYSE: WGO), a small-cap manufacturer of recreation vehicles (RVs),by 15.5 percent, to 2,728,377 shares of Common Stock,...
-
Korn/Ferry Expected To Deliver High Single-Digits EPS Growth
Wednesday, June 10, 2015 - 3:33pm | 371Shares of Korn/Ferry International (NYSE: KFY) are rising Wednesday afternoon ahead of the announcement of the company’s fourth-quarter financial results, scheduled for after the market closes on Thursday. Expectations According to Estimize, expectations point towards a 7 to 9 percent year...
-
Hologic Jumps On Goldman Sachs News; Icahn And Other Fund Managers Are Also Bullish
Thursday, December 18, 2014 - 5:43pm | 289Goldman Sachs added Hologic, Inc. (NASDAQ: HOLX) to its Conviction Buy list on Thursday, raising its price target from $30.00 to $33.00. The stock reacted positively to the news and rose more than 2 percent on Thursday. Jefferies, too, appears to like this $7.4 billion market cap medical...